Previously, the oncogenic role of AGPAT2, another member of the AGPAT gene family, has been reported in leukemia [26], pancreatic [27], and ovarian cancers [28–30], as well as in cisplatin chemoresistance in osteosarcoma [23]. This evidence concerns the gene AGPAT2 and ovarian cancer.